Zasya Life Sciences

Zasya Life Sciences

Hyderabad, India· Est.

An Indian CDMO providing end-to-end synthetic chemistry and manufacturing services for small molecule drug discovery, with a focus on oncology.

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

AI Company Overview

An Indian CDMO providing end-to-end synthetic chemistry and manufacturing services for small molecule drug discovery, with a focus on oncology.

Oncology

Technology Platform

Integrated synthetic and medicinal chemistry platform for small molecule discovery and development, specializing in complex chemistries, route scouting, and scalable process optimization.

Opportunities

Growth opportunities include capitalizing on increased outsourcing of chemistry R&D by global biopharma, expanding service offerings into newer modalities, and forming strategic risk-sharing partnerships to move beyond fee-for-service models.

Risk Factors

Key risks include high competition in the Indian CDMO sector, potential margin pressure, reliance on client R&D budgets, and the operational challenges of maintaining consistent quality and scalability across diverse projects.

Competitive Landscape

Competes with other Indian chemistry CDMOs like Syngene, Aragen Life Sciences, and GVK BIO, as well as global players. Differentiation is claimed through expertise in complex molecule synthesis and integrated, end-to-end service offerings designed to minimize technology transfer.